LeonaBio (LONA) Enterprise Value (2019 - 2026)

LeonaBio (LONA) has 8 years of Enterprise Value data on file, last reported at -$67.7 million in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$67.7 million, down 84.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$67.7 million (down 84.56% YoY), and the FY2025 annual result was -$88.3 million, down 72.27% from the prior year.
• Enterprise Value rose to -$67.7 million in Q1 2026 per LONA's latest filing, from -$88.3 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$25.2 million in Q3 2025 and troughed at -$263.5 million in Q1 2022.
• A 5-year average of -$130.0 million and a median of -$122.1 million in 2024 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2025 and 2026: Enterprise Value surged 69.96% in 2025, then sank 84.56% in 2026.
• A 5-year view of Enterprise Value shows it stood at -$200.3 million in 2022, then increased by 26.42% to -$147.4 million in 2023, then surged by 65.22% to -$51.3 million in 2024, then sank by 72.27% to -$88.3 million in 2025, then gained by 23.38% to -$67.7 million in 2026.
• Business Quant data shows LONA's Enterprise Value at -$67.7 million in Q1 2026, -$88.3 million in Q4 2025, and -$25.2 million in Q3 2025.